The Notice of Allowance for First Wave Bio's patent application indicates that the company has successfully protected its intellectual property for methods and compositions related to treating conditions associated with abnormal inflammatory responses. This may lead to the development of new treatments and products, potentially increasing the company's revenue and positively impacting its stock price in the short term.